HCB301

· FBD Biologics Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HCB301, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors [Phase 1]

See pricing